BV

Bahram Valamehr

FT Fate Therapeutics: 33 patents #1 of 36Top 3%
OC Ono Pharmaceutical Co.: 1 patents #329 of 559Top 60%
📍 San Diego, CA: #1,129 of 23,606 inventorsTop 5%
🗺 California: #15,031 of 386,348 inventorsTop 4%
Overall (All Time): #104,531 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #TitleCo-InventorsDate
12419870 Compositions and methods for immune cell modulation in adoptive immunotherapies Jonathan Rosen, Betsy Rezner, Ryan Bjordahl, Eigen Peralta, Ian Hardy 2025-09-23
12415989 Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs Ramzey Abujarour, Peter Flynn 2025-09-16
12410403 Methods and compositions for inducing hematopoietic cell differentiation Raedun Clarke, Ryan Bjordahl 2025-09-09
12398373 Enhanced immune effector cells and use thereof Ryan Bjordahl, Jode GOODRIDGE, Tom Tong LEE 2025-08-26
12385012 Methods and compositions for inducing hematopoietic cell differentiation Raedun Clarke 2025-08-12
12351831 Platform for the induction and maintenance of ground state pluripotency Megan Robinson, Ramzey Abujarour 2025-07-08
12281329 Compositions and methods for immune cell modulation in adoptive immunotherapies Jonathan Rosen, Betsy Rezner, Ryan Bjordahl, Eigen Peralta 2025-04-22
12275955 Combining iPSC derived effector cell types for immunotherapy use Jode GOODRIDGE, Ryan Bjordahl 2025-04-15
12264322 Minimal volume reprogramming of mononuclear cells Peter Flynn 2025-04-01
12247226 Cellular reprogramming using temporal and transient plasmid vector expression system Megan Robinson 2025-03-11
12203098 Cells having solid tumor targeting backbone and use thereof Tom Tong LEE, Martin Hosking, Eigen Peralta, Chia-Wei Chang 2025-01-21
12173274 Enhanced immune effector cells and use thereof Ryan Bjordahl, Jode GOODRIDGE, Tom Tong LEE 2024-12-24
12122846 Chimeric antigen receptor for tumor targeting Tom Tong LEE, Martin Hosking, Susumu YAMAMOTO, Tatsuo Maeda 2024-10-22
11851677 Composition and methods for inducing myeloid suppressive cells and use thereof Philippe A. Parone, Robert S. Tacke, Daniel Shoemaker, Martin Hosking, Lisa Guerrettaz 2023-12-26
11634688 Methods and compositions for inducing hematopoietic cell differentiation Raedun Clarke 2023-04-25
11441126 Platform for the induction and maintenance of ground state pluripotency Megan Robinson, Ramzey Abujarour 2022-09-13
11413309 Compositions and methods for immune cell modulation in adoptive immunotherapies Jonathan Rosen, Betsy Rezner, Ryan Bjordahl, Eigen Peralta, Ian Hardy 2022-08-16
11365394 Enhanced immune effector cells and use thereof Ryan Bjordahl, Jode GOODRIDGE, Tom Tong LEE 2022-06-21
11352607 Genomic engineering of pluripotent cells Ramzey Abujarour, Tom Tong LEE, Weijie Lan, Raedun Clarke, Ryan Bjordahl 2022-06-07
11268069 Reprogramming methods and cell culture platforms Peter Flynn, Ramzey Abujarour, Megan Robinson 2022-03-08
11162075 Methods and compositions for inducing hematopoietic cell differentiation Raedun Clarke, Ryan Bjordahl 2021-11-02
11162076 Methods and compositions for inducing hematopoietic cell differentiation Raedun Clarke, Ryan Bjordahl 2021-11-02
11096964 Compositions and methods for immune cell modulation in adoptive immunotherapies Jonathan Rosen, Betsy Rezner, Ryan Bjordahl, Eigen Peralta 2021-08-24
11072781 Genomic engineering of pluripotent cells Ramzey Abujarour, Tom Tong LEE, Weijie Lan, Raedun Clarke, Ryan Bjordahl 2021-07-27
10954529 Minimal volume reprogramming of mononuclear cells Peter Flynn 2021-03-23